Drug
Diclofenac Diethylamine 2 32
Diclofenac Diethylamine 2 32: highest development phase Phase 3, developed by GlaxoSmithKline. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- GlaxoSmithKline
Trials
| Drug | Phase | Indication |
|---|---|---|
| Diclofenac diethylamine 2.32% gel NCT04052620 | Phase 3 | Pain |
Latest
No recent events.
Follow Diclofenac Diethylamine 2 32 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.